Imbria Pharmaceuticals Strengthens Leadership with New Board and Key Clinical Appointments
September 16, 2025 Imbria Pharmaceuticals Strengthens Leadership with New Board and Key Clinical Appointments Pavan Cheruvu, MD, will serve as Independent Chair of the Board of Directors James Januzzi, MD, appointed to Senior Research Advisor and Scientific Advisory Board Chair BOSTON, Mass., September 16, 2025 — Imbria Pharmaceuticals, Inc., (“Imbria”), a clinical-stage company transforming […]